164 related articles for article (PubMed ID: 14544810)
1. Development of thrombolytic agents.
Lijnen HR; Collen D
Biotechnol Adv; 1993; 11(1):115-30. PubMed ID: 14544810
[TBL] [Abstract][Full Text] [Related]
2. Thrombolytic therapy.
Collen D
Thromb Haemost; 1997 Jul; 78(1):742-6. PubMed ID: 9198249
[TBL] [Abstract][Full Text] [Related]
3. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
4. Novel thrombolytic agents.
Verstraete M; Lijnen HR
Cardiovasc Drugs Ther; 1994 Dec; 8(6):801-11. PubMed ID: 7742258
[TBL] [Abstract][Full Text] [Related]
5. New thrombolytic agents and strategies.
Collen D; Lijnen HR
Baillieres Clin Haematol; 1995 Jun; 8(2):425-35. PubMed ID: 7549072
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic agents: mechanisms of activity and pharmacology.
Lijnen HR; Collen D
Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic agents in development.
Verstraete M; Lijnen HR; Collen D
Drugs; 1995 Jul; 50(1):29-42. PubMed ID: 7588087
[TBL] [Abstract][Full Text] [Related]
8. Remaining perspectives of mutant and chimeric plasminogen activators.
Lijnen HR; Collen D
Ann N Y Acad Sci; 1992 Dec; 667():357-64. PubMed ID: 1309056
[TBL] [Abstract][Full Text] [Related]
9. New thrombolytic drugs.
Thomson A
Aust N Z J Med; 1999 Jun; 29(3):433-5. PubMed ID: 10868516
[TBL] [Abstract][Full Text] [Related]
10. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
11. New developments in thrombolytic therapy.
Collen DC; Gold HK
Thromb Res Suppl; 1990; 10():105-31. PubMed ID: 2180114
[TBL] [Abstract][Full Text] [Related]
12. [Development of new thrombolytic substances].
Zeymer U; Neuhaus KL
Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
[TBL] [Abstract][Full Text] [Related]
13. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
14. New developments in thrombolytic therapy.
Collen D; Gold HK
Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
[TBL] [Abstract][Full Text] [Related]
15. Current developments in thrombolytic therapy using novel plasminogen activators.
Seifried E; Tanswell P
Arzneimittelforschung; 1989 Nov; 39(11):1474-82. PubMed ID: 2695093
[TBL] [Abstract][Full Text] [Related]
16. [Arterial permeability, objective of thrombolytic therapy].
Bassand JP; Schiele F; Bernard Y; Anguenot T
Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409
[TBL] [Abstract][Full Text] [Related]
17. [Antibody mediated thrombolysis. A new therapeutic principle].
Bode C; Kübler W
Klin Wochenschr; 1989 Jul; 67(13):651-8. PubMed ID: 2502649
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy.
Collen D; Stump DC; Gold HK
Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
[TBL] [Abstract][Full Text] [Related]
19. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
20. Third-generation thrombolytic drugs.
Verstraete M
Am J Med; 2000 Jul; 109(1):52-8. PubMed ID: 10936478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
